About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
KU Hematology & Medical Oncology Review 2019
Lung
Hematologic Malignancies
Gastrointestinal
Head and Neck
Genitourinary
Skin
Palliative
General
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
KU ASCO 2019 Updates on Trial Discussing Nivolumab + Ipilimumab in Melanoma Brain Metastases
By
KU Hematology & Medical Oncology Review 2019
FEATURING
Gary Doolittle
By
KU Hematology & Medical Oncology Review 2019
FEATURING
Gary Doolittle
250 views
August 22, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
20:59
Exelixis
Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…
Feat.
S. Ratnam
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Skin
12:46
KU Hematology & Medical Oncology Review 2019
KU ASCO 2019 Update on Surgical Treatment of Melanoma & Adjuvant…
Feat.
G. Doolittle
07:50
KU Hematology & Medical Oncology Review 2019
KU ASCO 2019 Updates on Trial Discussing Nivolumab + Ipilimumab in M…
Feat.
G. Doolittle
08:44
KU Hematology & Medical Oncology Review 2019
KU ASCO 2019 Long-Term Survival of Dabrafenib Plus Trametinib in Met…
Feat.
G. Doolittle